Fairholme Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fairholme Capital Management's PFE Position: Q3 2026 in Review
Fairholme Capital Management held its Pfizer (PFE) position steady in Q3 2026 at 231,000 shares worth $6.59M. The position accounts for 0.43% of the portfolio, ranked #8.
Fairholme Capital Management first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Fairholme Capital Management held 231,000 shares of Pfizer worth $6.59M as of Q3 2026.
- Fairholme Capital Management left its Pfizer share count unchanged in Q3 2026.
- Pfizer made up 0.43% of Fairholme Capital Management's portfolio in Q3 2026, its #8 holding.
- Fairholme Capital Management first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Fairholme Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.